Rao GH et al. |
Ibuprofen protects platelet cyclooxygenase from irreversible inhibition by aspirin. |
1983 Jul-Aug |
Arteriosclerosis |
pmid:6411052
|
Buchanan MR and Hirsh J |
Effect of aspirin and salicylate on platelet-vessel wall interactions in rabbits. |
1984 Jul-Aug |
Arteriosclerosis |
pmid:6380468
|
Best LC et al. |
Studies on the role of calcium in the control of thromboxane B2 production. |
1980 |
Artery |
pmid:6783015
|
Silver MJ et al. |
A model system for studying initial events in atherosclerosis. |
1980 |
Artery |
pmid:7000044
|
Kawai VK et al. |
Suboptimal inhibition of platelet cyclooxygenase 1 by aspirin in systemic lupus erythematosus: association with metabolic syndrome. |
2014 |
Arthritis Care Res (Hoboken) |
pmid:24022862
|
Kojima F et al. |
Membrane-associated prostaglandin E synthase-1 is upregulated by proinflammatory cytokines in chondrocytes from patients with osteoarthritis. |
2004 |
Arthritis Res. Ther. |
pmid:15225371
|
Chin JE and Lin YA |
Effects of recombinant human interleukin-1 beta on rabbit articular chondrocytes. Stimulation of prostanoid release and inhibition of cell growth. |
1988 |
Arthritis Rheum. |
pmid:3263134
|
Simon LS et al. |
Preliminary study of the safety and efficacy of SC-58635, a novel cyclooxygenase 2 inhibitor: efficacy and safety in two placebo-controlled trials in osteoarthritis and rheumatoid arthritis, and studies of gastrointestinal and platelet effects. |
1998 |
Arthritis Rheum. |
pmid:9751091
|
Shi T et al. |
Anti-beta2-glycoprotein I antibodies in complex with beta2-glycoprotein I can activate platelets in a dysregulated manner via glycoprotein Ib-IX-V. |
2006 |
Arthritis Rheum. |
pmid:16868978
|
Anzellotti P et al. |
Low-dose naproxen interferes with the antiplatelet effects of aspirin in healthy subjects: recommendations to minimize the functional consequences. |
2011 |
Arthritis Rheum. |
pmid:21360514
|
Stein CM et al. |
Evidence of free radical-mediated injury (isoprostane overproduction) in scleroderma. |
1996 |
Arthritis Rheum. |
pmid:8670323
|
Cracowski JL et al. |
Enhanced in vivo lipid peroxidation in scleroderma spectrum disorders. |
2001 |
Arthritis Rheum. |
pmid:11352247
|
Ferro D et al. |
Determinants of enhanced thromboxane biosynthesis in patients with systemic lupus erythematosus. |
1999 |
Arthritis Rheum. |
pmid:10616019
|
Fauler J et al. |
Enhanced synthesis of cysteinyl leukotrienes in juvenile rheumatoid arthritis. |
1994 |
Arthritis Rheum. |
pmid:8129769
|
Walker JS et al. |
Nonsteroidal antiinflammatory drugs in rheumatoid arthritis and osteoarthritis: support for the concept of "responders" and "nonresponders". |
1997 |
Arthritis Rheum. |
pmid:9365082
|
Weinblatt M et al. |
The effects of cyclosporin A on eicosanoid excretion in patients with rheumatoid arthritis. |
1991 |
Arthritis Rheum. |
pmid:2012627
|
Vega-Ostertag M et al. |
Intracellular events in platelet activation induced by antiphospholipid antibodies in the presence of low doses of thrombin. |
2004 |
Arthritis Rheum. |
pmid:15457460
|
Wakamoto S et al. |
Effects of hemoglobin vesicles on resting and agonist-stimulated human platelets in vitro. |
2005 |
Artif Cells Blood Substit Immobil Biotechnol |
pmid:15960075
|
Szebeni J et al. |
Complement activation and thromboxane secretion by liposome-encapsulated hemoglobin in rats in vivo: inhibition by soluble complement receptor type 1. |
1997 |
Artif Cells Blood Substit Immobil Biotechnol |
pmid:9242930
|
Gu YJ et al. |
Biocompatibility of leukocyte removal filters during leukocyte filtration of cardiopulmonary bypass perfusate. |
1993 |
Artif Organs |
pmid:8338443
|
Simoni J et al. |
Biocompatibility of hemoglobin solutions. II. The inflammatory reaction of human monocytes and mouse peritoneal macrophages. |
1990 |
Artif Organs |
pmid:2350262
|
Mahiout A et al. |
Dialyzer membranes: effect of surface area and chemical modification of cellulose on complement and platelet activation. |
1987 |
Artif Organs |
pmid:3036050
|
Hatori N et al. |
Biocompatibility of heparin-coated membrane oxygenator during cardiopulmonary bypass. |
1994 |
Artif Organs |
pmid:7887827
|
Kim WG et al. |
Is avoidance of air contact necessary for the in vitro evaluation of thrombogenicity in mechanical circulatory assist devices? |
2000 |
Artif Organs |
pmid:11012543
|
Jörres A et al. |
Urinary excretion of thromboxane and markers for renal injury in patients undergoing cardiopulmonary bypass. |
1994 |
Artif Organs |
pmid:7527629
|
Mahiout A et al. |
Eicosanoid release as laboratory indicator of biocompatibility. |
1989 |
Artif Organs |
pmid:2504134
|
Feola M et al. |
Biocompatibility of hemoglobin solutions. I. Reactions of vascular endothelial cells to pure and impure hemoglobins. |
1989 |
Artif Organs |
pmid:2669694
|
Yoshino T et al. |
Pharmacological profile of celecoxib, a specific cyclooxygenase-2 inhibitor. |
2005 |
Arzneimittelforschung |
pmid:16080279
|
Okuda Y et al. |
Hemodynamic effects of cilostazol on peripheral artery in patients with diabetic neuropathy. |
1992 |
Arzneimittelforschung |
pmid:1642679
|
Küsters S et al. |
Effects of antihistamines on leukotriene and cytokine release from dispersed nasal polyp cells. |
2002 |
Arzneimittelforschung |
pmid:11878205
|
Moriau M et al. |
Platelet anti-aggregant and rheological properties of piracetam. A pharmacodynamic study in normal subjects. |
1993 |
Arzneimittelforschung |
pmid:8457235
|
Legnani C et al. |
Effects of a dried garlic preparation on fibrinolysis and platelet aggregation in healthy subjects. |
1993 |
Arzneimittelforschung |
pmid:8457236
|
Hladovec J |
Prostaglandins and endothelial stability. |
1981 |
Arzneimittelforschung |
pmid:7011332
|
Ortega MP et al. |
Effect of etersalate on human platelet responsiveness. A study in healthy volunteers. |
1987 |
Arzneimittelforschung |
pmid:2883981
|
Horiguchi T et al. |
Study on the usefulness of seratrodast in the treatment of chronic pulmonary emphysema. |
2002 |
Arzneimittelforschung |
pmid:12442639
|
Tanaka M et al. |
Disposition and effect of the new thromboxane synthetase inhibitor 6-(1-imidazolylmethyl)-5,6,7,8-tetrahydronaphthalene-2-carboxylic acid in man. |
1990 |
Arzneimittelforschung |
pmid:2397009
|
Kangasaho M |
Effects of lidocaine, codeine and vadocaine hydrochloride on platelet aggregation in human platelet-rich plasma. |
1988 |
Arzneimittelforschung |
pmid:2840087
|
Maurin N |
Routine measurement of thromboxane B2 and the prostacyclin metabolite 6-keto-prostaglandin F1 alpha in plasma. |
1986 |
Arzneimittelforschung |
pmid:3778554
|
Perzborn E et al. |
Action of the novel selective thromboxane antagonist (3R)-3-(4-fluorophenylsulfonamido)-1,2,3,4-tetrahydro-9-carbazolepropan oic acid on vascular smooth muscle preparations. |
1989 |
Arzneimittelforschung |
pmid:2624598
|
Supanz S et al. |
Effects of the novel thromboxane (TXA2) receptor antagonist linotroban on inulin and para-aminohippuric acid clearances in the conscious male and female rat. |
1997 |
Arzneimittelforschung |
pmid:9342416
|
Berti F et al. |
Protective effect of furosemide combined with non-steroidal anti-inflammatory drugs administered by inhalation route on guinea-pigs anaphylaxis model. |
1995 |
Arzneimittelforschung |
pmid:8595068
|
Ohmuro S et al. |
Protective effect of the new antiplatelet agent 2-methyl-3-(1,4,5,6-tetrahydronicotinoyl)pyrazolo[1,5-a]pyridine on myocardial damage due to coronary occlusion and reperfusion in rabbit. |
1992 |
Arzneimittelforschung |
pmid:1586378
|
Uehara S et al. |
Effects of the calcium antagonist nifedipine on thromboxane B2 level and platelet aggregation in hypertensive patients. |
1986 |
Arzneimittelforschung |
pmid:3814228
|
Matsuzawa S et al. |
Ibudilast, a phosphodiesterase inhibitor, in combination with low-dose aspirin potently inhibits guinea pig carotid artery thrombosis without extending bleeding time and causing gastric mucosal injury. |
2012 |
Arzneimittelforschung |
pmid:22945770
|
Tubaro E et al. |
Anti-inflammatory and antiplatelet effects of amtolmetin guacyl, a new gastroprotective non-steroidal anti-inflammatory drug. |
2001 |
Arzneimittelforschung |
pmid:11642006
|
Depin JC et al. |
Pharmacodynamics and antithrombotic effects after intravenous administration of the new thromboxane A2 receptor antagonist sodium 4-[[1-[[[(4-chlorophenyl)sulfonyl]amino]methyl]cyclopentyl] methyl]benzeneacetate. |
1994 |
Arzneimittelforschung |
pmid:7848332
|
Asai F et al. |
In vitro antiplatelet profiles of the new thromboxane synthetase inhibitor sodium 2-(1-imidazolylmethyl)-4,5-dihydrobenzo[b]thiophene-6-carboxylate. |
1991 |
Arzneimittelforschung |
pmid:1898421
|
Rettkowski W et al. |
Studies of the influence of nitroglycerin on the synthesis of prostaglandins and thromboxane A2 and on platelet aggregation. |
1982 |
Arzneimittelforschung |
pmid:6805480
|
Kawakage M et al. |
Beneficial effect of the novel thromboxane A2 receptor antagonist sodium (E)-11-[2-(5,6-dimethyl-1-benzimidazolyl)ethylidene]-6,11- dihydrodibenz[b,e]oxepine-2-carboxylate monohydrate on collagen-induced coronary ischemia in guinea-pigs. |
1991 |
Arzneimittelforschung |
pmid:1815524
|
Keller F et al. |
Thromboxane B2 blood levels and incipient system clotting in heparin free hemodialysis. |
1995 Apr-Jun |
ASAIO J. |
pmid:7640422
|
Amrani DL et al. |
Hemostatic evaluation of Sarns/3M-VAD implantation in calves. |
1991 Jul-Sep |
ASAIO Trans |
pmid:1751163
|
Mahiout A et al. |
Prostaglandin production and extracorporeal complement activation by dialyzer membranes. |
1986 Jul-Sep |
ASAIO Trans |
pmid:3490868
|
Ito RK et al. |
Monitoring platelet interactions with prosthetic graft implants in a canine model. |
1990 Jul-Sep |
ASAIO Trans |
pmid:2147555
|
Takayama K et al. |
Changes in endothelial vasoactive substances under recombinant human erythropoietin therapy in hemodialysis patients. |
1991 Jul-Sep |
ASAIO Trans |
pmid:1836334
|
Hain H et al. |
Prostaglandin E2, thromboxane B2, and leukotriene B4 release from peritoneal macrophages by different osmotic agents in nonuremic guinea pigs. |
1988 Jul-Sep |
ASAIO Trans |
pmid:2848562
|
Mahiout A et al. |
Modified cellulosic dialyzer membranes: an investigative tool in thrombogenicity studies. |
1988 Jul-Sep |
ASAIO Trans |
pmid:3058187
|
Murphy KJ et al. |
Low dose supplementation with two different marine oils does not reduce pro-inflammatory eicosanoids and cytokines in vivo. |
2006 |
Asia Pac J Clin Nutr |
pmid:16837436
|
Eynard AR et al. |
Platelet formation of 12-hydroxyeicosatetraenoic acid and thromboxane B2 is increased in type IIA hypercholesterolemic subjects. |
1986 |
Atherosclerosis |
pmid:3085686
|
Bailey JM et al. |
Anti-inflammatory drugs in experimental atherosclerosis. Part 4. Inhibition of atherosclerosis in vivo and thromboxane synthesis and platelet aggregation in vitro. |
1979 |
Atherosclerosis |
pmid:454516
|
Tremoli E et al. |
Metformin reduces platelet hypersensitivity in hypercholesterolemic rabbits. |
1982 |
Atherosclerosis |
pmid:7073794
|
Lovati MR et al. |
Reduced platelet aggregability and increased vascular prostacyclin formation in a variant rat strain (IVA-SIV) with endogenous hypertriglyceridemia. |
1988 |
Atherosclerosis |
pmid:3214476
|
Menys VC et al. |
Spontaneous platelet aggregation in whole blood is increased in non-insulin-dependent diabetes mellitus and in female but not male patients with primary dyslipidemia. |
1995 |
Atherosclerosis |
pmid:7772062
|
Fredenrich A et al. |
Effects of low density and high density lipoproteins isolated from non-insulin dependent diabetic patients on prostaglandin secretion by mouse macrophage cell line P388D1. |
1999 |
Atherosclerosis |
pmid:9920525
|
Chiang MT et al. |
Lipoprotein, lecithin:cholesterol acyl transferase and acetyl CoA carboxylase in stroke-prone spontaneously hypertensive rats fed a diet high in eicosapentaenoic acid. |
1994 |
Atherosclerosis |
pmid:7912508
|
Croft KD et al. |
Leukocyte and platelet function and eicosanoid production in subjects with hypercholesterolaemia. |
1990 |
Atherosclerosis |
pmid:2173612
|
Livio M et al. |
Differential effects of itanoxone--a new hypolipidemic and hypouricemic drug--on platelet and vascular prostaglandin generation in rats. |
1981 |
Atherosclerosis |
pmid:7259827
|
Malle E et al. |
Effects of dietary fish oil supplementation on platelet aggregability and platelet membrane fluidity in normolipemic subjects with and without high plasma Lp(a) concentrations. |
1991 |
Atherosclerosis |
pmid:1832537
|
Jeng JH et al. |
Antiplatelet effect of sanguinarine is correlated to calcium mobilization, thromboxane and cAMP production. |
2007 |
Atherosclerosis |
pmid:16797553
|
Bräutigam R et al. |
Arachidonic acid of platelet phospholipids is decreased after extracorporeal removal of plasma low density lipoproteins in patients with familial hypercholesterolemia. |
1997 |
Atherosclerosis |
pmid:9180250
|
Beatty CH et al. |
Metabolism of arachidonic acid by macaque platelets. Implications for studies on atherosclerosis. |
1985 |
Atherosclerosis |
pmid:3924062
|
Dembińska-Kièć A et al. |
Prostacyclin-dependent differences in TXA2 formation by platelets from normal and atherosclerotic rabbits. |
1979 |
Atherosclerosis |
pmid:224890
|
Davì G et al. |
Effects of synvinolin on platelet aggregation and thromboxane B2 synthesis in type IIa hypercholesterolemic patients. |
1989 |
Atherosclerosis |
pmid:2803348
|
McClelland S et al. |
Contribution of cyclooxygenase-1 to thromboxane formation, platelet-vessel wall interactions and atherosclerosis in the ApoE null mouse. |
2009 |
Atherosclerosis |
pmid:18514659
|
Puccetti L et al. |
Effects of atorvastatin and rosuvastatin on thromboxane-dependent platelet activation and oxidative stress in hypercholesterolemia. |
2011 |
Atherosclerosis |
pmid:21056418
|
Balteskard L et al. |
Thromboxane production in the blood of women increases after menopause whereas tumor necrosis factor is reduced in women compared with men. |
1993 |
Atherosclerosis |
pmid:8257457
|
Huang K et al. |
Role of selenium in cytoprotection against cholesterol oxide-induced vascular damage in rats. |
2002 |
Atherosclerosis |
pmid:11947907
|
Kleinedler JJ et al. |
A dietary approach to increase in-stent stenosis and face validity of a rat model for arterial angioplasty and stenting. |
2011 |
Atherosclerosis |
pmid:21982412
|
Beitz J et al. |
Endogenous lipoproteins modify the thromboxane formation capacity of platelets. |
1986 |
Atherosclerosis |
pmid:3718615
|
Véricel E et al. |
The influence of low intake of n-3 fatty acids on platelets in elderly people. |
1999 |
Atherosclerosis |
pmid:10525140
|
Ledwidge MT et al. |
In vivo impact of prodrug isosorbide-5-nicotinate-2-aspirinate on lipids and prostaglandin D2: is this a new immediate-release therapeutic option for niacin? |
2012 |
Atherosclerosis |
pmid:22326030
|
Mustad V et al. |
Seasonal variation in parameters related to coronary heart disease risk in young men. |
1996 |
Atherosclerosis |
pmid:8879440
|
Tremoli E et al. |
Dietary interventions in north Karelia, Finland and south Italy. Modification of thromboxane B2 formation in platelets of male subjects only. |
1986 |
Atherosclerosis |
pmid:3964338
|
Abeywardena MY et al. |
Long-term saturated fat supplementation in the rat causes an increase in PGI2/TXB2 ratio of platelet and vessel wall compared to n-3 and n-6 dietary fatty acids. |
1987 |
Atherosclerosis |
pmid:2820432
|
Cyrus T et al. |
Stabilization of advanced atherosclerosis in low-density lipoprotein receptor-deficient mice by aspirin. |
2006 |
Atherosclerosis |
pmid:16326168
|
Bogani P et al. |
Postprandial anti-inflammatory and antioxidant effects of extra virgin olive oil. |
2007 |
Atherosclerosis |
pmid:16488419
|
Singer P et al. |
Long-term effect of mackerel diet on blood pressure, serum lipids and thromboxane formation in patients with mild essential hypertension. |
1986 |
Atherosclerosis |
pmid:3026412
|
Falco A et al. |
Inhibition of thromboxane biosynthesis by triflusal in type 2 diabetes mellitus. |
2005 |
Atherosclerosis |
pmid:16285996
|
Gross PL et al. |
Platelet hypersensitivity in cholesterol-fed rabbits: enhancement of thromboxane A2-dependent and thrombin-induced, thromboxane A2-independent platelet responses. |
1991 |
Atherosclerosis |
pmid:1878012
|
Singer P et al. |
Blood pressure- and lipid-lowering effect of mackerel and herring diet in patients with mild essential hypertension. |
1985 |
Atherosclerosis |
pmid:3000395
|
Clark IA and Hunt NH |
Increased production of arachidonate metabolites by peritoneal cells of mice infected with Plasmodium vinckei vinckei. |
1986 |
Aust J Exp Biol Med Sci |
pmid:3579736
|
Croft KD et al. |
Dietary modification of platelet and renal prostaglandins. |
1984 |
Aust N Z J Med |
pmid:6393931
|
Herd CM et al. |
A dose-ranging study of the antiplatelet effect of enteric coated aspirin in man. |
1987 |
Aust N Z J Med |
pmid:3476058
|
Vial JH et al. |
Selective inhibition of platelet cyclooxygenase with controlled release, low-dose aspirin. |
1990 |
Aust N Z J Med |
pmid:2126726
|
Cooper TM and Ingram DM |
Platelet function in the peri-operative period. |
1991 |
Aust N Z J Surg |
pmid:1829351
|
Tachi M et al. |
Mass spectrometric determination of prostanoids in rat hypothalamic paraventricular nucleus microdialysates. |
2014 |
Auton Neurosci |
pmid:24447364
|
Shen D and Wang Y |
Effects of hypoxia on platelet activation in pilots. |
1994 |
Aviat Space Environ Med |
pmid:7945133
|
Ylikorkala O and Viinikka L |
The role of prostaglandins in obstetrical disorders. |
1992 |
Baillieres Clin Obstet Gynaecol |
pmid:1477999
|
Markuszewski L et al. |
Reduced blood platelet sensitivity to aspirin in coronary artery disease: are dyslipidaemia and inflammatory states possible factors predisposing to sub-optimal platelet response to aspirin? |
2006 |
Basic Clin. Pharmacol. Toxicol. |
pmid:16635110
|
Jin YR et al. |
An antithrombotic agent, NQ301, inhibits thromboxane A2 receptor and synthase activity in rabbit platelets. |
2005 |
Basic Clin. Pharmacol. Toxicol. |
pmid:16128910
|
Calapai G et al. |
Cardiovascular biomarkers in groups of established smokers after a decade of smoking. |
2009 |
Basic Clin. Pharmacol. Toxicol. |
pmid:19175368
|